FACTOR CERTIFICATE LONG - MABION Share Price

Certificat

RCFL3MAB1

AT0000A2WE19

Market Closed - Warsaw S.E. 16:55:50 04/07/2024 BST
0.25 PLN 0.00% Intraday chart for FACTOR CERTIFICATE LONG - MABION
Date Price Change
04/07/24 0.25 0.00%
03/07/24 0.25 0.00%
02/07/24 0.25 0.00%
01/07/24 0.25 0.00%
28/06/24 0.25 0.00%

Delayed Quote Warsaw S.E.

Last update July 04, 2024 at 04:55 pm

More quotes

Static data

Product typeProductos Exóticos
Buy / SellCALL
Underlying MABION S.A.
Issuer Raiffeisen Bank International
RCFL3MAB1
ISINAT0000A2WE19
Date issued 23/03/2022
Strike 11.68
Maturity Unlimited
Parity 19.3 : 1
Emission price 10
Emission volume N/A
Settlement Por diferencias
Currency PLN

Technical Indicators

Highest since issue 10
Lowest since issue 0.22

Company Profile

Mabion SA is a Poland-based company engaged in the research and development of biotechnological and biopharmaceutical medicinal products. Mabion SA was founded by four pharmaceutical companies, including Celon Pharma Ltd, Polfarmex Co, Genexo Ltd and IBSS Biomed Co, as well as two companies focused on research and development in biotechnology field, including BioCentrum Ltd and Biotech Consulting Ltd. The Company specializes in the humanized monoclonal antibodies (mAbs) technology, a new generation of biotechnological drugs. It focuses on oncology drugs used to treat blood cancer, lymphomas and leukemias, rheumatoid arthrisis, as well as breast cancer. It operates its own Research and Development Center in the Special Economical Zone in Lodz, Poland.
Sector
-
More about the company

Ratings for Mabion S.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Mabion S.A.

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
3
Last Close Price
16.98 PLN
Average target price
15.83 PLN
Spread / Average Target
-6.75%
Consensus
  1. Stock Market
  2. Certificates
  3. RCFL3MAB1 Certificat